These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 4121460

  • 1. Chlorambucil in steroid-dependent nephrotic syndrome.
    Grupe WE.
    J Pediatr; 1973 Apr; 82(4):598-606. PubMed ID: 4121460
    [No Abstract] [Full Text] [Related]

  • 2. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR.
    N Z Med J; 1989 Jul 26; 102(872):379-81. PubMed ID: 2797556
    [Abstract] [Full Text] [Related]

  • 3. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE, Makker SP, Ingelfinger JR.
    N Engl J Med; 1976 Sep 30; 295(14):746-9. PubMed ID: 958261
    [Abstract] [Full Text] [Related]

  • 4. Management of the nephrotic syndrome.
    Linshaw MA, Gruskin AB.
    Clin Pediatr (Phila); 1974 Jan 30; 13(1):45-51. PubMed ID: 4588668
    [No Abstract] [Full Text] [Related]

  • 5. [Chlorambucil in the treatment of idiopathic nephrotic syndrome without glomrular lesions in childhood. Apropos of 30 cases].
    Lévèque B, Debauchez C, Deflandre L, Marie J.
    Ann Pediatr (Paris); 1969 Jan 02; 16(1):13-23. PubMed ID: 5791870
    [No Abstract] [Full Text] [Related]

  • 6. Steroid-dependent nephrotic syndrome in lupus nephritis. Response to chlorambucil.
    Abuelo JG, Esparza AR, Garella S.
    Arch Intern Med; 1984 Dec 02; 144(12):2411-2. PubMed ID: 6508447
    [Abstract] [Full Text] [Related]

  • 7. Long-term assessment of chlorambucil in children with nephrotic syndrome who fail to respond adequately to corticosteroids.
    Pascual JF, Molina M, Lopez J.
    Contrib Nephrol; 1981 Dec 02; 27():65-74. PubMed ID: 7285590
    [No Abstract] [Full Text] [Related]

  • 8. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood.
    Williams SA, Makker SP, Ingelfinger JR, Grupe WE.
    N Engl J Med; 1980 Apr 24; 302(17):929-33. PubMed ID: 6987521
    [Abstract] [Full Text] [Related]

  • 9. Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial.
    Baluarte HJ, Hiner L, Gruskin AB.
    J Pediatr; 1978 Feb 24; 92(2):295-8. PubMed ID: 621612
    [Abstract] [Full Text] [Related]

  • 10. How to manage a child with steroid-responsive nephrotic syndrome when dose of prednisolone is reduced or when placed on high-dose alternate day steroids.
    Niaudet P.
    Pediatr Nephrol; 1992 Nov 24; 6(6):522. PubMed ID: 1482637
    [No Abstract] [Full Text] [Related]

  • 11. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    N Engl J Med; 1982 Feb 25; 306(8):451-4. PubMed ID: 7035953
    [Abstract] [Full Text] [Related]

  • 12. Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia.
    Han T, Ezdinli EZ, Shimaoka K, Desai DV.
    Cancer; 1973 Mar 25; 31(3):502-8. PubMed ID: 4693581
    [No Abstract] [Full Text] [Related]

  • 13. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
    Chiu J, McLaine PN, Drummond KN.
    J Pediatr; 1973 Apr 25; 82(4):607-13. PubMed ID: 4698337
    [No Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J, Drummond KN.
    J Pediatr; 1974 Jun 25; 84(6):825-30. PubMed ID: 4855503
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.
    Niaudet P.
    Pediatr Nephrol; 1992 Jan 25; 6(1):1-3. PubMed ID: 1536727
    [Abstract] [Full Text] [Related]

  • 16. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R, Brem AS.
    Pediatrics; 1989 Sep 25; 84(3):495-9. PubMed ID: 2771553
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
    McCrory WW, Shibuya M, Lu WH, Lewy JE.
    J Pediatr; 1973 Apr 25; 82(4):614-8. PubMed ID: 4698338
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 Apr 25; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of corticoid-resistant nephrotic syndrome: a still unresolved problem].
    Damiani B, Giani M, Consalvo G, Carcano A, Ghio L, Edefonti A.
    Pediatr Med Chir; 1995 Apr 25; 17(1):9-15. PubMed ID: 7739938
    [Abstract] [Full Text] [Related]

  • 20. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug 24; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.